Manufacturing

Results: 1 - 9 of 42
view
Cobra Biologics, Pall Corporation and CGT Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies

Cobra Biologics,has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation...

Read more
view
Press release: Research Highlights the UK’s Growing Industry and Infrastructure for Manufacturing Cell and Gene Therapies

This year’s major investment in the size and scale of the UK’s manufacturing capability supports...

Read more
view
Press release: Stevenage Cell and Gene Therapy Catapult centre gets green light to make new cell and gene therapies

New life-changing cell and gene therapies for use in health services around the world will be...

Read more
view
July news: Stevenage cluster supporting company and industry growth

In this newsletter you can find out how the cell and gene therapy manufacturing cluster in...

Read more
view
CGT Catapult granted £3.36m to support increased capacity at Stevenage manufacturing centre

£3.36m European Regional Development Fund (ERDF) award will support the construction of a...

Read more
view
Ministers visit CGT Catapult manufacturing centre and attend opening event

On Monday 23rd April, Business Secretary Greg Clark and Science Minister Sam Gyimah opened our...

Read more
view
Cell and Gene Therapy Catapult opens manufacturing centre to accelerate growth of the industry in the UK

Business Secretary Greg Clark and Science Minister Sam Gyimah officially opened centre to ‘...

Read more
view
Press release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline Therapeutics

Freeline will develop a ‘next-generation’ therapy platform at CGT Catapult’s UK-based large-...

Read more
view
GMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacity

The Cell and Gene Therapy Catapult review of MHRA licensed GMP manufacturing facilities in the...

Read more

Discover who we are

 
Sign up